NCT06348992 ACT Combined Yoga for Parental Burnout in Parents with Autistic Children
| NCT ID | NCT06348992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Harbin Medical University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-01 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
OBJECTIVE: To explore the intervention effect of ACT combined with a yoga intervention program on parenting burnout in parents with ASD. METHODS: This study used a combination of qualitative research and quantitative analysis to examine the intervention effects of an ACT-centered intervention program on parenting burnout in parents of children with ASD, and to clarify the evaluations and perceptions of parents with ASD about the research program through qualitative research. RESULTS AND CONCLUSION: To clarify the intervention effect of ACT combined with yoga intervention program on parenting burnout of ASD parents.
Eligibility Criteria
Inclusion Criteria: * Parents of children diagnosed with ASD based on DSM-5 * Parental burnout exists in parents * Parents have normal speech, hearing and cognitive functioning * Is the primary caregiver for children * Informed consent and voluntary participation Exclusion Criteria: * Untreated ongoing or severe psychiatric disorders such as anxiety disorders, depressive disorders, schizophrenia, etc.; * other more serious psychosomatic disorders that would interfere with the intervention.
Contact & Investigator
Quanzhi Zhang, Doctor
STUDY CHAIR
Harbin Medical University
Frequently Asked Questions
Who can join the NCT06348992 clinical trial?
This trial is open to participants of all sexes, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06348992 currently recruiting?
Yes, NCT06348992 is actively recruiting participants. Contact the research team at cjy071949@163.com for enrollment information.
Where is the NCT06348992 trial being conducted?
This trial is being conducted at Daqing, China.
Who is sponsoring the NCT06348992 clinical trial?
NCT06348992 is sponsored by Harbin Medical University. The principal investigator is Quanzhi Zhang, Doctor at Harbin Medical University. The trial plans to enroll 60 participants.